The Sox9 transcription factor plays an essential role in promoting chondrogenesis and regulating expression of chondrocyte extracellular-matrix genes. To identify genes that interact with Sox9 in promoting chondrocyte differentiation, we screened a cDNA library generated from the murine chondrogenic ATDC5 cell line to identify activators of the collagen, type II, α 1 (Col2a1) promoter. Here we have shown that paraspeckle regulatory protein 54-kDa nuclear RNA-binding protein (p54 nrb ) is an essential link between Sox9-regulated transcription and maturation of Sox9-target gene mRNA. We found that p54 nrb physically interacted with Sox9 and enhanced Sox9-dependent transcriptional activation of the Col2a1 promoter. In ATDC5 cells, p54 nrb colocalized with Sox9 protein in nuclear paraspeckle bodies, and knockdown of p54 nrb suppressed Sox9-dependent Col2a1 expression and promoter activity. We generated a p54 nrb mutant construct lacking RNA recognition motifs, and overexpression of mutant p54 nrb in ATDC5 cells markedly altered the appearance of paraspeckle bodies and inhibited the maturation of Col2a1 mRNA. The mutant p54 nrb inhibited chondrocyte differentiation of mesenchymal cells and mouse metatarsal explants. Furthermore, transgenic mice expressing the mutant p54 nrb in the chondrocyte lineage exhibited dwarfism associated with impairment of chondrogenesis. These data suggest that p54 nrb plays an important role in the regulation of Sox9 function and the formation of paraspeckle bodies during chondrogenesis.
Introduction
Chondrogenesis is an important biological event in endochondral bone development, skeletogenesis, and tissue patterning (1, 2) . After condensation of chondrogenic mesenchymal cells, they begin to differentiate into chondrocytes (3) . The transcription factor Sox9 contains a SRY-related high-mobility group box and promotes chondrocyte differentiation and the expression of cartilage-specific extracellular matrix genes, including collagens and proteoglycans (3) . In humans, heterozygous SOX9 mutations cause campomelic dysplasia characterized by severe chondrodysplasia (4, 5) . Heterozygous Sox9 mutant mice or mice lacking Sox9 function show impaired endochondral bone formation (6, 7) . These findings indicate that Sox9 plays an essential role in chondrogenesis.
Sox9 is also implicated in the expression of Sox5 and Sox6, both of which form a transcriptional complex with Sox9 to control the expression of collagen, type II, α 1 (Col2a1) and aggrecan (Acan) during chondrocyte differentiation (7) . In addition, PGC-1α functions as a transcriptional coactivator for Sox9 (8) . Moreover, the functional and physical interaction of Sox9 and β-catenin is important evidence for crosstalk between Sox9 and Wnt signaling (9) . These findings have contributed to identification of transcriptional components for Sox9 that are implicated in chondrogenesis. However, other modes of the regulation of chondrogenic genes, including chromatin remodeling, histone modification, and RNA processing, are not well understood.
Because the transcription factors form a large complex that sequentially and dynamically controls expression of target genes in collaboration with the partner molecules, identification of the components of the "transcriptional factory" formed by Sox9 would lead to a breakthrough in our understanding of the mechanisms of Sox9-regulated chondrogenesis. In this study, we identify 54-kDa nuclear RNA-binding protein (p54 nrb ) as an interacting partner of Sox9 and show that p54 nrb controls transcription and mRNA processing of the Col2a1 gene. Furthermore, we demonstrate that p54 nrb plays an important role in chondrogenesis in vitro and in vivo. Thus p54 nrb is an essential transcriptional regulator that links the Sox9-dependent transcription to target gene mRNA maturation during chondrogenesis.
Results

Physical and functional interaction of p54 nrb with Sox9.
To identify factors involved in Sox9-mediated regulation of chondrocyte differentiation, we screened a cDNA library generated from the chondrogenic cell line, ATDC5 (10) , by performing a luciferase reporter assay using the Col2a1 gene promoter. Four cDNA clones stimulated the Col2a1 gene promoter ( Figure 1A) . One of these encodes the full-length p54 nrb protein (11) (12) (13) , which contains 2 RNA recognition motifs (RRMs) and is localized to nuclear paraspeckle bodies (14) . We have confirmed that p54 nrb mRNA is expressed in ATDC5 cells and in primary mouse chondrocytes (data not shown). To examine the functional relationship between p54 nrb and Sox9, we determined the effect of p54 nrb on the transcriptional activity of Sox9. Overexpression of p54 nrb markedly enhanced Sox9 transactivation of the Col2a1 gene promoter ( Figure 1B) . We did not observe the upregulation of the Col2a1 promoter activity by p54 nrb in HeLa cells where Sox9 is not expressed ( Figure 1C ). In contrast, p54 nrb did not affect the transcriptional activity of Runx2, an essential transcription factor for osteoblast differentiation (15) (Figure 1D ), suggesting that p54 nrb specifically stimulates the transcriptional activity of Sox9. To investigate the basis of the functional cooperation between p54 nrb and Sox9, we tested whether p54 nrb and Sox9 proteins interact. As shown in Figure 1E , coimmunoprecipitation experiments indicated a physical association between p54 nrb and Sox9. These results indicate that p54 nrb functions as a transcriptional partner for Sox9. Next we attempted to define whether the functional interaction between p54 nrb and Sox9 is required for regulation of the Col2a1 gene promoter activity. Overexpression of a dominant-negative Sox9 mutant, which lacks binding activity to p54 nrb , markedly inhibited stimulation of Col2a1 promoter activity by p54 nrb (Figure 2, A and B) . A mutant of p54 nrb , ΔM, which lacks binding activity to Sox9 (Figure 2 , C and D), failed to stimulate the transcriptional activity of Sox9 ( Figure  2E ). Furthermore, knockdown of p54 nrb (Figure 2 , F and G) clearly inhibited transcriptional activity of Sox9 on the Col2a1 gene promoter ( Figure 2H ). These results demonstrated that p54 nrb is a critical transcriptional partner of Sox9 and that this partnership upregulates Col2a1 gene promoter activity.
Interaction of p54 nrb and Sox9 in paraspeckle nuclear bodies. It has been reported that p54 nrb colocalizes and interacts with paraspeckle protein 1 (PSP1) in the paraspeckle nuclear bodies (14, 16) . Although nuclear paraspeckles are assumed to be involved in nuclear events, including DNA replication, transcription, and mRNA maturation (17) , their biological roles remain unclear. First, we determined the subcellular localization of p54 nrb in ATDC5 cells using Venustagged p54 nrb . p54 nrb was confined to the nucleus within nuclear speckles ( Figure 3A ) and colocalized with PSP1 ( Figure 3A) but not with SC-35 ( Figure 3B ), a nuclear speckle body protein implicated in RNA splicing (18, 19) . Consistent with results shown in Figure 1 . Because the size of nuclear speckle has been shown previously to be inversely correlated with the state of transcription of the cell (17) , our data suggest that interaction between p54 nrb and Sox9 stimulates transcriptional activity.
Role of p54 nrb in mRNA processing of Col2a1. Because 2 RRMs of p54 nrb are highly homologous to the RRM domain of poly-pyrimidine tract-binding protein-associated splicing factor (PSF), we speculated that p54 nrb is involved in splicing of the target genes necessary for chondrogenesis. We examined the processing of Col2a1 mRNA by performing a minigene assay using a Col2a1 gene cassette, containing the alternatively spliced exon 2 driven by the native promoter (20) . Overexpression of Sox9 or p54 nrb produced a spliced transcript of the Col2a1 (IIA) containing exon 2 (20, 21) (Figure 4, A and B) . Furthermore, co-overexpression of Sox9 and p54 nrb produced more transcripts of Col2a1 (IIA) than expression of Sox9 or p54 nrb alone ( Figure 4, A and B) . In addition, co-overexpression of Sox9 and p54 nrb also produced type II B isoform ( Figure 4A ), which is preferentially expressed in differentiated chondrocytes (21) . However, p54 nrb is not involved in splicing of the fibronectin gene ( Figure 4C ). These results suggest that p54 nrb specifically controls the splicing and maturation of Col2a1 mRNA. To further understand the role of p54 nrb in this process, we generated a mutant of p54 nrb (Δ224), lacking 2 RRMs ( Figure  2C ). In ATDC5 cells in which the mutant was expressed, the shape of paraspeckle bodies was rounded ( Figure 5A ), without affecting the proliferation of ATDC5 cells ( Figure 5B ), and not colocalized with SC-35 ( Figure 5C ). Interestingly, however, the mutant p54 nrb still upregulated the transcriptional activity of Sox9 ( Figure 5D ) and retained the binding capacity to Sox9 ( Figure 2D ). In addition, where mutant p54 nrb colocalized with Sox9, the size of speckles was smaller ( Figure 5E ). Next, we evaluated the role of both the p54 nrb RRM and paraspeckle nuclear bodies in the processing of Col2a1 mRNA. Overexpression of the mutant p54 nrb blocked the maturation of Col2a1 mRNA ( Figure 5F ). We confirmed that this effect of the mutant p54 nrb is not due to inhibition of transcription of the minigene ( Figure 4B ). Collectively, the results indicate that p54 nrb regulates both the splicing of Col2a1 mRNA and the formation of paraspeckle bodies via RRMs.
Regulation of chondrocyte differentiation by p54 nrb . To investigate whether p54 nrb is involved in chondrogenesis, we examined its effect on chondrocyte differentiation. Overexpression of p54 nrb in ATDC5 cells induced the endogenous expression of Col2a1 and Acan ( Figure 6 , A-D). In contrast, knockdown of p54 nrb clearly inhibited Sox9-induced Col2a1 expression ( Figure 6E ). Next, we examined the effect of the p54 nrb mutant that impaired Col2a1 mRNA processing and paraspeckle body formation. Overexpression of the p54 nrb mutant dramatically inhibited Sox9-induced Col2a1 expression ( Figure 6 , C and D). Also, the mutant p54 nrb abolished bone morphogenetic protein 2-induced (BMP2-induced) chondrocyte differentiation ( Figure 6F ). On the other hand, the mutant p54 nrb did not affect BMP2-induced osteoblast differentiation ( Figure 6G ). Furthermore, organ culture experiments using mouse fetal metatarsals indicated that while wild-type p54 nrb stimulated chondrogenesis, the p54 nrb mutant suppressed it ( Figure 6 , H-J). These data indicate that p54 nrb plays a critical role in chondrocyte differentiation via its RRM domains.
Requirement of p54 nrb in chondrogenesis in vivo.
To demonstrate the importance of p54 nrb in chondrogenesis in vivo, we generated transgenic mice, in which the mutant p54 nrb is specifically expressed in the chondrocyte lineage, using the Col2a1 gene promoter (Figure 7 , A-C). Transgenic mice showed dwarfism between the neonatal period and 3 weeks after birth (Figure 7, D-H) . Histological analyses showed that the layer of proliferating chondrocytes was markedly thinner in the transgenic mice compared with wild-type littermates ( Figure 7I) . Consistent with the reduction in Col2a1 expression by overexpression of the mutant p54 nrb ( Figure  6 , C and D), Col2 expression was suppressed in the transgenic mice ( Figure 7 , J and K). These results indicate that p54 nrb plays a critical role in chondrocyte differentiation. To further understand the role of p54 nrb in chondrogenesis, we examined the transgenic mice at younger stage. As shown in Figure 8A , enchondral ossification at the birth was markedly impaired in the transgenic mice. In situ hybridization experiments also indicated the delayed chondrogenesis in the transgenic mice at E15 ( Figure 8B ). In contrast, consistent with the results shown in Figure 5B , proliferation of chondrocytes was not influenced in the transgenic mice. Collectively, these data suggest that inhibition of mRNA processing of Col2a1 by p54 nrb leads to delay of ossification, which resulted in dwarfism seen in the transgenic mice.
Discussion
The expression of the genes necessary for chondrogenesis is exquisitely and harmoniously regulated by several transcription factors (1) . Several lines of evidence demonstrate the indispensable role of Sox9 for the commitment of mesenchymal cells into chondrocytes and the early stages of chondrocyte differentiation (3). In the present study, we have identified p54 nrb as an important transcriptional partner of Sox9 during chondrogenesis. We found that p54 nrb stimulates the transcriptional activity of Sox9 and chondrogenic action of Sox9. In contrast, knockdown of p54 nrb inhibited the activity of Sox9. Consistently, a dominant-negative mutant of Sox9 dramatically suppressed the stimulatory effect of p54 nrb on Col2a1 promoter activity. The interaction between p54 nrb and Sox9 was confirmed by coimmunoprecipitation experiments and colocalization in the nucleus of ATDC5 cells and primary chondrocytes. Collectively, these results clearly indicate that p54 nrb forms a transcriptional factory with Sox9.
Because p54 nrb has been shown to play a role in regulation of splicing or termination of mRNA synthesis (22), we examined whether p54 nrb regulates the processing of Col2a1 mRNA. Minigene assay showed that p54 nrb overexpression stimulates the processing of Col2a1 mRNA. Moreover, the mutant of p54 nrb lacking RRMs inhibited Col2a1 mRNA processing. Consistently, the mutant p54 nrb also blocked Col2a1 expression induced by Sox9. However, interestingly, the mutant p54 nrb retains the ability to upregulate the transcriptional activity of Sox9 on the Col2a1 gene promoter. These results indicate that p54 nrb regulates both transcription and splicing of Col2a1 mRNA through 2 different functional domains during chondrocyte differentiation and that p54 nrb is a critical Sox9 transcriptional factory component that couples the transcription and processing of Col2a1 mRNA.
Several studies demonstrate that nuclear speckles are implicated in the regulation of transcription and splicing of target genes and, consequently, controlling of cell growth and differ- entiation (14, 23, 24) . p54 nrb is also implicated in formation of paraspeckle bodies with PSP1 (14) . However, the biological role of p54 nrb and paraspeckle body is unknown. In this study, we demonstrate that p54 nrb is critical for chondrogenesis. Overexpression of p54 nrb upregulated the expression of chondrogenic genes and stimulated chondrocyte differentiation in C3H10T1/2 cells. In the cells, knockdown experiments supported the importance of p54 nrb in chondrogenesis. In organ culture systems, p54 nrb stimulated chondrogenesis. Furthermore, overexpression of the p54 nrb mutant lacking RRMs suppressed chondrogenesis in vitro and in vivo. This mutation caused enlargement of paraspeckle size, without affecting the size of the authentic nuclear speckle formed by SC-35, which is also implicated in regulation of splicing of mRNA (18) . Interestingly, Sox9 is localized in the paraspeckle body and decreased its size. Collectively, our results raise a possibility that the RRM domain interaction of p54 nrb with Sox9 dynamically reg- ulates the paraspeckle formation and mRNA processing necessary for chondrocyte differentiation.
In conclusion, our findings provide what we believe to be the novel paradigm whereby linkage between transcription and mRNA processing by a paraspeckle regulatory protein is critical for chondrocyte development. Thus, this finding provides a novel insight to our knowledge into the molecular basis of Sox9 regulation and chondrogenesis.
Methods
Cell and reagents. C3H10T1/2, ATDC5, HeLa, C2C12, and HEK293 cells were purchased from RIKEN and were cultured in α-MEM containing 10% fetal bovine serum. BOSC23 cells were kindly provided by Sakae Tanaka (Tokyo University Medical School, Tokyo, Japan). Recombinant BMP2 was generated as described previously (25) . Anti-HA, anti-Myc, anti-SC-35, antiSox9, anti-p54 nbr , and anti-type II collagen antibodies were purchased from Sigma-Aldrich, Santa Cruz Biotechnology Inc., Upstate, and Novotec.
Molecular cloning of p54 nrb . The full-length cDNA library of ATDC5 cells was generated in a pME18S-FL3 expression vector as previously described (26, 27) . The 120,000 cDNA clones were screened using a luciferase reporter construct containing an 104-bp minimal promoter region and 4 copies of 48-bp Sox9-binding element but not any introduction of the Col2a1 gene (27) . One positive clone encodes a full-length of p54 nrb .
Constructs. HA-tagged wild-type and a dominant-negative mutant (aa 21-234) Sox9 have been described previously (28) . ΔHMG mutant (a mutant lacking the HMG domain) Sox9 (aa 181-510) was generated by subcloning of the corresponding PCR product into HA-tag pcDNA3 vector. DsRed-Nuc construct was purchased from Clontech. PSP1 cDNA was a kind gift from Angus Lamond (University of Dundee, Dundee, United Kingdom) (14) . To generate a mutant form of p54 nrb (Δ224), PCR products which encoded a portion of p54 nrb (aa 225-473) were subcloned into pcDNA3 (Invitrogen) tagged with a Flag epitope, Myc epitope, or Venus (an improved GFP) tag in N-terminus. The sequences of these constructs were confirmed by DNA sequence analysis. SRP40 cDNA was purchased from Open Biosystems Inc. Transfection of ATDC5 cells was carried out using Fugene6 (Roche) according to the manufacturer's protocol.
Reporter assay. The Col2a1 gene promoter fused to luciferase reporter construct was transfected to ATDC5 cells. Two days after transfection, cells were lysed, and luciferase activity was determined using specific substrates in a luminometer (Promega) according to manufacturer's protocol. Transfection efficiency was normalized by determining the activity of renilla luciferase.
Immunoprecipitation and immunoblotting analysis. The cells were washed 3 times with ice-cold PBS and solubilized in lysis buffer (29) . The lysates were centrifuged at 16,000 g for 15 minutes at 4°C and incubated with antibodies for 4 hours at 4°C, followed by immunoprecipitation with protein A-sepharose (Zymed) or protein G-agarose (Roche).
Immunoprecipitates were washed 5 times with lysis buffer and boiled in SDS sample buffer, and supernatants were recovered as immunoprecipitate samples.
Cell lysates, nuclear extracts, cell matrix extracts, or immunoprecipitated samples were isolated were determined by immunoblotting using anti-Myc, anti-HA, or anti-type II collagen antibodies (25) .
Production of recombinant His-tagged p54 nrb protein. PCR product containing the coding region of p54 nrb was subcloned into pCold vector (Takara). The construct was transformed into BL21 E.coli strain, and then His-tagged p54 nrb protein was generated and purified with Ni-NTA agarose beads (QIAGEN) according to the manufacturer's protocol. The purified His-tagged p54 nrb protein immobilized with the beads was used for binding assay with Sox9.
In vitro binding assay. Cell lysates were incubated with tandem affinity purification-tagged (TAP-tagged) Sox9 protein immobilized on IgG-Sepharose beads at 4°C for 2 hours. The beads were washed 5 times with lysis buffer, and then the proteins associated with TAP-tagged Sox9 were determined by immunoblotting using anti-Myc antibody. The association of p54 nrb with mutants of HA-tagged Sox9 was determined by immunoblotting with anti-HA antibody, following precipitation of cell lysates with recombinant Histagged p54 nrb protein.
Immunocytochemical and immunohistochemical analyses. Cultured cells were washed 3 times with ice-cold PBS and fixed with 3.7% paraformaldehyde-PBS for 20 minutes. After 20-minute incubation with 0.1% Triton X-100-PBS, the cells were blocked with 1% BSA-containing PBS for 2 hours, incubated with anti-SC-35 antibody in 1% BSA-containing PBS, and then washed 6 times with PBS and incubated with FITC-conjugated affinitypurified anti-mouse IgG antibody (The Jackson Laboratory). The cells were washed extensively with PBS and visualized by fluorescence microscope (Zeiss) or confocal microscope (Zeiss). ATDC5 cells transfected with Venusp54 nrb , Venus-p54 nrb (Δ224), DsRed-PSP1, or DsRed-Nuc (Clontech) were visualized by fluorescence microscope. Bones of mice were fixed in 3.8% formalin-PBS, decalcified in 4% EDTA, and then histologically analyzed by H&E staining and immunohistochemically analyzed using anti-type II collagen antibody. Undecalcified bone sections prepared from embryo or 
